China Health Industries Holdings, Inc.
China Health Industries Holdings, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | 5 | 5 | - | - | - | 7 | - | - | - | - | |||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 43 | 43 | 42 | 45 | 47 | 47 | 46 | 44 | |||||
Accounts Receivable Net Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Supplies | - | - | 0 | - | - | - | - | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 41 | 41 | 44 | 44 | 43 | 46 | 49 | 48 | 48 | 48 | |||||
Prepaid Insurance | - | - | 40 | 41 | - | - | - | - | - | - | - | - | |||||
Advances On Inventory Purchases | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Prepaid Expense Current | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |||||
Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Assets | 4 | 4 | 45 | 45 | 49 | 49 | 48 | 51 | 54 | 54 | 54 | 54 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities And Equity | |||||||||||||||||
Short Term Borrowings | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Other Liabilities | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 7 | 7 | 6 | 6 | 7 | 7 | 8 | 8 | 10 | 9 | 9 | 9 | |||||
Other Notes Payable Current | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | |||||
Customer Advances Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | |||||
Due To Related Parties Current | - | - | - | - | - | 6 | 6 | 7 | 7 | 8 | 8 | 8 | |||||
Debt Current | - | - | - | - | 6 | - | - | - | - | - | - | - | |||||
Other Liabilities Current | - | - | 5 | - | - | - | - | - | - | - | - | - | |||||
Accrued Salaries Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Taxes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital Common Stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Stockholders Equity | -2 | -2 | 39 | 39 | 42 | 42 | 40 | 43 | 45 | 45 | 45 | 45 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -3 | -3 | -3 | -3 | -1 | -1 | -2 | 1 | 3 | 3 | 2 | 2 | |||||
Retained Earnings Accumulated Deficit | 41 | 41 | 41 | 41 | 42 | 42 | 41 | 42 | 41 | 41 | 42 | 42 | |||||
Liabilities And Stockholders Equity | 4 | 4 | 45 | 45 | 49 | 49 | 48 | 51 | 54 | 54 | 54 | 54 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | |||||
Shares Outstanding | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -53.60% | -68.80% | -68.80% | 0.00% | 190.70% | 286.46% | -59.27% | -54.65% | -71.24% | - | - | - |
| 2023 | 103.41% | 103.41% | 30.35% | -7.89% | -37.50% | -37.50% | 40.38% | 40.38% | -6.50% | 0.00% | -68.80% | -68.80% |
| 2022 | 184.55% | -26.84% | -26.84% | 0.00% | 0.00% | 0.00% | 0.00% | -91.14% | -90.97% | 45.00% | 325.00% | 764.50% |
| 2021 | - | - | - | - | - | - | - | - | - | -47.59% | -65.41% | -48.64% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.04 | 0.04 | 6.82 | 6.86 | 6.68 | 6.75 | 5.55 | 5.74 | 5.11 | 5.22 | 5.44 | 5.24 | |||||
| Quick Ratio | 0.04 | 0.04 | 6.82 | 6.85 | 6.62 | 6.68 | 5.48 | 5.67 | 5.02 | 5.13 | 5.35 | 5.15 | |||||
| Working Capital | -6.28M | -6.31M | 34.69M | 35.00M | 37.41M | 37.37M | 35.13M | 37.65M | 39.08M | 38.97M | 38.89M | 38.62M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -2.72 | -2.86 | 0.15 | 0.15 | 0.16 | 0.15 | 0.19 | 0.19 | 0.21 | 0.21 | 0.20 | 0.20 | |||||
| Interest Coverage TTM | -27,626.96 | -36,478.07 | -1,535,835.00 | - | - | - | - | - | - | - | - | - | |||||
| Debt Ratio | 1.58 | 1.54 | 0.13 | 0.13 | 0.14 | 0.13 | 0.16 | 0.16 | 0.18 | 0.17 | 0.16 | 0.17 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.13 | |||||
| Days Sales Outstanding TTM | - | - | - | - | 54.15 | 158.94 | 3,578.42 | 1,610,671.18 | 2,063.66 | 845.51 | 222.34 | 196.16 | |||||
| Receivables Turnover TTM | - | - | - | - | 6.74 | 2.30 | 0.10 | 0.00 | 0.18 | 0.43 | 1.64 | 1.86 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.02 | -0.02 | -0.00 | -0.01 | 0.01 | 0.01 | -0.01 | -0.01 | -0.02 | -0.01 | 0.01 | 0.02 | |||||
| Free Cash Flow Per Share TTM | -0.65 | -0.65 | -0.65 | -0.64 | -0.01 | -0.00 | -0.00 | 0.03 | 0.08 | 0.09 | 0.10 | 0.08 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | -5.06% | -2.30% | 0.15% | - | - | - | - | -554.68% | 27.39% | 49.94% | 55.81% | 56.09% | |||||
| Operating Profit Margin TTM | -1,439.71% | -1,337.50% | -1,024.72% | -1,261.52% | -2,095.96% | -2,744.40% | -4,936.04% | -617,199.63% | -308.40% | -70.46% | 12.68% | 28.71% | |||||
| Net Profit Margin TTM | -1,419.55% | -1,287.18% | -89.86% | -279.86% | 793.31% | 1,063.31% | -2,288.04% | -132,565.54% | -263.68% | -62.71% | 14.65% | 19.89% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 8.36% | 74.69% | 334.63% | 54,604.87% | -79.53% | -94.46% | -99.20% | -100.00% | -94.66% | -87.56% | -57.29% | -34.63% | |||||
| Net Income Growth (1Y) | -293.89% | -311.47% | -82.93% | 15.49% | -161.59% | -193.98% | -225.23% | -127.41% | -159.02% | -126.90% | -81.65% | -63.64% | |||||
| EPS Growth (1Y) | -293.89% | -311.47% | -82.93% | 15.49% | -161.59% | -193.98% | -225.23% | -127.41% | -159.02% | -126.90% | -81.65% | -63.64% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -14.07 | -21.17 | -1,459.89 | -35.87 | 13.06 | 15.87 | -16.45 | -1.98 | -6.94 | -10.42 | 26.11 | 10.29 | |||||
| P/B TTM | -7.99 | -13.95 | 5.08 | 0.37 | 0.22 | 0.27 | 0.33 | 0.02 | 0.18 | 0.18 | 0.37 | 0.30 | |||||
| P/S TTM | 199.74 | 272.44 | 1,311.85 | 100.38 | 103.62 | 168.80 | 376.32 | 2,626.50 | 18.29 | 6.53 | 3.82 | 2.05 | |||||
| Market Cap | 19.16M | 31.95M | 196.62M | 14.66M | 9.18M | 11.33M | 12.98M | 701.28K | 7.91M | 7.91M | 16.45M | 13.28M | |||||
| Enterprise Value | 19.18M | 31.97M | 196.61M | 14.61M | -28.39M | -31.84M | -29.14M | -44.09M | -39.50M | -39.15M | -29.49M | -31.06M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -42.79M | -42.82M | -42.29M | -42.27M | -366.38K | -171.25K | -181.42K | 2.12M | 5.44M | 6.01M | 6.71M | 5.55M | |||||
| Net Debt | 16.53K | 19.84K | -12.47K | -47.25K | -37.57M | -43.17M | -42.12M | -44.79M | -47.41M | -47.07M | -45.94M | -44.35M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
China Health Industries Holdings, Inc. (CHHE) — SEC Financial Statements & Analysis
China Health Industries Holdings, Inc. (CHHE) is a pharmaceutical preparations company. China Health Industries Holdings, Inc. trades on OTC as: CHHE. Based on its latest SEC filing (Form 10-Q, period ending 2024-03-31), China Health Industries Holdings, Inc. reported a 8.36% year-over-year revenue growth, a Gross Profit Margin of -5.06% (TTM), a Debt-to-Equity ratio of -2.72x, a Price-to-Sales (P/S) ratio of 199.74x (TTM), a Price-to-Book (P/B) ratio of -7.99 (TTM), at a market cap of $19.16M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 8.36%
- Gross Profit Margin TTM
- -5.06%
- Debt To Equity
- -2.72x
- P/S TTM
- 199.74x
- P/B TTM
- -7.99
- Market Cap
- $19.16M
Data as of 2024-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is China Health Industries Holdings, Inc. in?
China Health Industries Holdings, Inc. (CHHE) operates in the Pharmaceutical Preparations industry.
What is CHHE's market cap?
China Health Industries Holdings, Inc. (CHHE) has a market capitalization of $19.16M as of 2024-03-31.
What exchange does CHHE trade on?
China Health Industries Holdings, Inc. (CHHE) trades on the OTC.